Cargando…
A Prospective Case–control Trial to Evaluate and Compare the Efficacy and Safety of Atosiban versus Placebo in In vitro Fertilization-embryo Transfer Program
BACKGROUND: Recent developments in assisted reproductive technology focus on potential advances to improve its success rate. Atosiban, a combined oxytocin/vasopressin V1a receptor antagonist, is a novel class of drug involved in basic priming of the uterus for successful implantation during embryo t...
Autores principales: | Mishra, Vineet, Agarwal, Himani, Goel, Sugandha, Roy, Priyankur, Choudhary, Sumesh, Lamba, Sunita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094537/ https://www.ncbi.nlm.nih.gov/pubmed/30158812 http://dx.doi.org/10.4103/jhrs.JHRS_7_17 |
Ejemplares similares
-
The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis
por: Huang, Qian-Yi, et al.
Publicado: (2017) -
Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles
por: Li, Xiufang, et al.
Publicado: (2023) -
Uterine conserving surgery in a case of cervicovaginal agenesis with unicornuate uterus
por: Mishra, Vineet, et al.
Publicado: (2016) -
Iron Deficiency Anemia with Menorrhagia: Ferric Carboxymaltose a Safer Alternative to Blood Transfusion
por: Mishra, Vineet, et al.
Publicado: (2018) -
Atosiban improves the outcome of embryo transfer. A systematic review and meta-analysis of randomized and non-randomized trials
por: Schwarze, Juan Enrique, et al.
Publicado: (2020)